According to Bliss GVS Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.55653. At the end of 2023 the company had a P/S ratio of 1.72.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.72 | 71.47% |
2022 | 1.00 | -33.88% |
2021 | 1.52 | -61.66% |
2020 | 3.96 | 108.04% |
2019 | 1.90 | -3.27% |
2018 | 1.97 | -19.26% |
2017 | 2.44 | 5.59% |
2016 | 2.31 | -25.07% |
2015 | 3.08 |